Release of PAI-1 by Human Preadipocytes and Adipocytes Independent of Insulin and IGF-1

This publication has 30 references indexed in Scilit:

• Posttranscriptional regulation of plasminogen activator inhibitor-1 in human lung carcinoma cells in vitro
  American Journal of Physiology-Lung Cellular and Molecular Physiology, 2000
• Insulin but not IGF-I is required for the maintenance of the adipose phenotype in the adipogenic cell line 1246
  In Vitro Cellular & Developmental Biology – Animal, 1999
• Synthesis and Secretion of Plasminogen Activator Inhibitor-1 by Human Preadipocytes
  Journal of Clinical Endocrinology & Metabolism, 1999
• Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients
  International Journal of Cancer, 1998
• Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells
  Proceedings of the National Academy of Sciences, 1998
• Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women
  International Journal of Obesity, 1998
• The Adipocyte and Hemostatic Balance in Obesity
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1998
• Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease
  Diabetes, 1997
• Sex steroids regulate the expression of plasminogen activator inhibitor-1 (PAI-1) and its mRNA in uterine endometrial cancer cell line Ishikawa
  The Journal of Steroid Biochemistry and Molecular Biology, 1996
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985